| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe256f2e07b1769466465082fbd31ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85f666a2c624d026b304e70458f126ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5c3d199d39c9e72eb1d2a319ce50202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c39c4b2f527baf08b7eb349a79e7f3e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0356
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0393 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2001-12-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b8c0f02ccf72016f901d72eacc0821c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae4fc3c5d24d66c658b05f51f44574a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c11ab0640a351454a1f4ee56c58b923 |
| publicationDate |
2002-06-20^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0247478-A2 |
| titleOfInvention |
Transgenic mice containing proliferator-activated receptor gene disruptions |
| abstract |
The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising mutations n proliferator-activated receptors. Such transgenic mice are useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004006662-A1 |
| priorityDate |
2000-12-11^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |